Cellular biomolecules in illuminated tissue

Cellular biomolecules in illuminated tissue refers to a diverse group of endogenous molecules, such as proteins, lipids, and nucleic acids, that interact with light to produce biological effects. This term is often used in the context of photodynamic therapy (PDT) and photobiomodulation, where light-sensitive molecules (chromophores) absorb photons to trigger chemical reactions (Karu, 1999). In PDT, exogenous photosensitizers like Porfimer sodium accumulate in tissues and, upon illumination, transfer energy to oxygen, creating reactive oxygen species (ROS) that damage these cellular biomolecules (National Cancer Institute, 2023). Key endogenous targets include cytochrome c oxidase in the mitochondria, which is a primary photoacceptor for red and near-infrared light, influencing cellular energy metabolism (Hamblin, 2017). Because this term describes a broad environment and a collection of various molecular species rather than a single protein or receptor, it is not considered a specific therapeutic target in the traditional pharmacological sense. Instead, it represents the substrate for light-based medical interventions used to treat cancers, skin conditions, and age-related macular degeneration (StatPearls, 2023). The interaction between light and these biomolecules can lead to localized cell death, immune response modulation, or enhanced tissue repair depending on the light parameters used.

Other names

Endogenous chromophoresPhotoacceptorsPhotodynamic targetsLight-sensitive cellular components

Photoactivation of endogenous or exogenous sensitizers leads to the production of reactive oxygen species (ROS), which cause oxidative damage to cellular biomolecules, resulting in cell death or signaling changes (National Cancer Institute, 2023).